Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 3;12(13):4463.
doi: 10.3390/jcm12134463.

Efficacy of Serum Ferritin-Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis

Kei Moriya  1   2 , Shinya Sato  1 , Norihisa Nishimura  1 , Hideto Kawaratani  1 , Hiroaki Takaya  1 , Kosuke Kaji  1 , Tadashi Namisaki  1 , Masakazu Uejima  1   2 , Shinsaku Nagamatsu  1   2 , Hideki Matsuo  1   2 , Hitoshi Yoshiji  1
Affiliations

Efficacy of Serum Ferritin-Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis

Kei Moriya et al. J Clin Med. .

Abstract

Background/Aims: The search for noninvasive biomarkers that can efficiently estimate the extent of liver fibrosis progression is ongoing. Although Fibrosis-4 (FIB-4), the aspartate transaminase-to-platelet ratio index (APRI), and the Forns index have been reported as useful biomarkers, their investigation in autoimmune hepatitis (AIH) is limited. This study aimed to examine the usefulness of these serological indices and a newly developed index in predicting liver fibrosis progression in AIH. Methods: The study analyzed data from 190 patients diagnosed with AIH at our institution between 1990 and 2015. Their histological liver fibrosis progression and clinical long-term prognosis were evaluated retrospectively (cohort 1). In 90 patients, receiver operating characteristic (ROC) curves were compared to choose severe fibrosis cases with respect to existing indices (FIB-4, APRI, and Forns index) and the ferritin-zinc ratio (cohort 2). Results: In cohort 1, liver-related death and hepatocellular carcinoma rates were significantly higher in the severe (n = 27) than in the mild (n = 63) fibrosis group (p = 0.0001 and 0.0191, respectively). In cohort 2, liver-related death in the severe fibrosis group was significantly frequent (p = 0.0071), and their ferritin-zinc ratio was higher (median 2.41 vs. 0.62, p = 0.0011). ROC analyses were performed to compare the ability of the ferritin-zinc ratio, FIB-4, APRI, and the Forns index to predict severe and mild fibrosis. Accordingly, areas under the ROC were 0.732, 0.740, 0.721, and 0.729, respectively. Conclusions: The serum ferritin-zinc ratio can noninvasively predict liver fibrosis progression in AIH and be applied to predict long-term prognosis.

Keywords: autoimmune hepatitis; biomarker; ferritin; liver fibrosis; zinc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of patients in this study. In cohort 1, liver-related death-free survival and HCC-free survival were evaluated in patients with AIH. In cohort 2, the efficacy of serum biomarkers for predicting long-term prognosis was evaluated in patients with AIH. AIH, autoimmune hepatitis; HCC, hepatocellular carcinoma.
Figure 2
Figure 2
Relations between the degree of liver fibrosis progression and major clinical outcomes. (a) Liver-related death-free survival in the mild and severe liver fibrosis groups in cohort 1 (n = 198). (b) HCC-free survival in the mild and severe liver fibrosis groups in cohort 1 (n = 198). (c) Liver-related death-free survival in the mild and severe liver fibrosis groups in cohort 2 (n = 90). (d) HCC-free survival in the mild and severe liver fibrosis groups in cohort 2 (n = 90). HCC, hepatocellular carcinoma.
Figure 3
Figure 3
Relationship between blood inorganic salt balance and liver fibrosis progression in patients with AIH. (a) Relations between serum zinc and ferritin concentration in patients with autoimmune hepatitis. (b) Serum ferritin–zinc ratio classified by liver fibrosis progression. AIH, autoimmune hepatitis.
Figure 4
Figure 4
Efficacy of various serum biomarkers in predicting severe hepatic fibrosis of patients with AIH. ROC curve analysis. (a) ROC curve for ferritin–zinc ratio (AUC = 0.732, sensitivity = 62%, specificity = 80%). (b) ROC curves for FIB-4 (AUC = 0.740, sensitivity = 71%, specificity = 74%). (c) ROC curves for APRI (AUC = 0.721, sensitivity = 64%, specificity = 80%). (d) ROC curves for Forns index (AUC = 0.729, sensitivity = 54%, specificity = 89%). AIH, autoimmune hepatitis; APRI, aspartate transferase to platelet ratio index; AUC, area under the curve; ROC, receiver operating characteristic.
Figure 5
Figure 5
Relations between the level of ferritin–zinc ratio and major clinical outcomes. (a) Liver-related death-free survival in cohort 2 (n = 90). (b) HCC-free survival in cohort 2 (n = 90). FZR, ferritin–zinc ratio; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

References

    1. Tanaka A., Mori M., Matsumoto K., Ohira H., Tazuma S., Takikawa H. Increase trend in the prevalence and Male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol. Res. 2019;49:881–889. doi: 10.1111/hepr.13342. - DOI - PubMed
    1. Wong G.L., Hui V.W., Yip T.C., Liang L.Y., Zhang X., Tse Y.K., Lai J.C., Chan H.L., Wong V.W. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma. Aliment. Pharmacol. Ther. 2022;56:869–877. doi: 10.1111/apt.17120. - DOI - PubMed
    1. Estirado Gómez A., Justo Gil S., Limia A., Avellón A., Arce Arnáez A., González-Rubio R., Diaz A., Del Amo J., Working group of the HCV prevalence study in Spain in 2017–2018 Prevalence and undiagnosed fraction of hepatitis C infection in 2018 in Spain: Results from a national population-based survey. Eur. J. Public Health. 2021;31:1117–1122. doi: 10.1093/eurpub/ckab069. - DOI - PubMed
    1. Angulo P., Kleiner D.E., Dam-Larsen S., Adams L.A., Bjornsson E.S., Charatcharoenwitthaya P., Mills P.R., Keach J.C., Lafferty H.D., Stahler A., et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389–397.e10. doi: 10.1053/j.gastro.2015.04.043. - DOI - PMC - PubMed
    1. Danielsson Borssén Å., Marschall H.U., Bergquist A., Rorsman F., Weiland O., Kechagias S., Nyhlin N., Verbaan H., Nilsson E., Werner M. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis. Scand. J. Gastroenterol. 2017;52:1022–1028. doi: 10.1080/00365521.2017.1335772. - DOI - PubMed

LinkOut - more resources